Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Chromium
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Mend Nutrition, Inc | Keller Consulting Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life
Details : Chromium is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 10, 2022
Lead Product(s) : Chromium
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Mend Nutrition, Inc | Keller Consulting Group
Deal Size : Inapplicable
Deal Type : Inapplicable